LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | N13 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | G19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | N21 |
MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | K17 |
MCF 10A-H2B-mCherry | Taxol | 0.001 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | C18 |
MCF 10A-H2B-mCherry | Vorinostat | 0.01 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | J11 |
MCF 10A-H2B-mCherry | Taxol | 0.000043333 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | I16 |
MCF 10A-H2B-mCherry | Vorinostat | 5.6234 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | E07 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | E05 |
MCF 10A-H2B-mCherry | Etoposide | 1 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | L21 |
MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | H17 |
MCF 10A-H2B-mCherry | 0 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | D21 | |
MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | K18 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 5.36 | 27.76 | 5 | 320 | 0.0156 | -0.3848 | MN20160318_Q01 | M14 |
MCF 10A-H2B-mCherry | Alpelisib | 0.1 | 5.36 | 27.76 | 5 | 320 | 0.0156 | -0.3848 | MN20160318_Q01 | M16 |
MCF 10A-H2B-mCherry | 0 | 5.36 | 27.76 | 5 | 320 | 0.0156 | -0.3848 | MN20160318_Q01 | K09 | |
MCF 10A-H2B-mCherry | Alpelisib | 10 | 5.36 | 27.76 | 5 | 320 | 0.0156 | -0.3848 | MN20160318_Q01 | H04 |
MCF 10A-H2B-mCherry | Alpelisib | 0.031667 | 5.36 | 27.76 | 5 | 320 | 0.0156 | -0.3848 | MN20160318_Q01 | K22 |
MCF 10A-H2B-mCherry | Taxol | 0.31623 | 46.95 | 84.90 | 5 | 4952 | 0.0010 | -0.3829 | MN20160318_Q02 | K15 |
MCF 10A-H2B-mCherry | Etoposide | 10 | 46.95 | 84.90 | 5 | 4952 | 0.0010 | -0.3829 | MN20160318_Q02 | F18 |
MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 46.95 | 84.90 | 5 | 4952 | 0.0010 | -0.3829 | MN20160318_Q02 | G21 |
MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 11.18 | 84.90 | 25 | 492 | 0.0508 | -0.3825 | MN20160318_Q02 | C22 |
MCF 10A-H2B-mCherry | Taxol | 0.017783 | 41.11 | 27.76 | 1 | 3331 | 0.0003 | -0.3820 | MN20160318_Q01 | G20 |
MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 41.11 | 27.76 | 1 | 3331 | 0.0003 | -0.3820 | MN20160318_Q01 | K17 |